Cited by 141Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsCardiac pacing and defibrillation studies

The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Open access

Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boersma, L., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Casadei, B., Clemens, A., Crijns, H., Derwand, R., Dobrev, D., Ezekowitz, M., Fetsch, T., Gerth, A., Gillis, A., Gulizia, M., Hack, G., Haegeli, L., Hatem, S., Georg Hausler, K., Heidbuchel, H., Hernandez-Brichis, J., Jais, P., Kappenberger, L., Kautzner, J., Kim, S., Kuck, K.-H., Lane, D., Leute, A., Lewalter, T., Meyer, R., Mont, L., Moses, G., Mueller, M., Munzel, F., Nabauer, M., Nielsen, J. C., Oeff, M., Oto, A., Pieske, B., Pisters, R., Potpara, T., Rasmussen, L., Ravens, U., Reiffel, J., Richard-Lordereau, I., Schafer, H., Schotten, U., Stegink, W., Stein, K., Steinbeck, G., Szumowski, L., Tavazzi, L., Themistoclakis, S., Thomitzek, K., Van Gelder, I. C., von Stritzky, B., Vincent, A., Werring, D., Willems, S., Lip, G. Y. H., Camm, A. J.·2013·Europace

DOI 10.1093/europace/eut232

Open this paper in CoChat — free account Open PDF

Abstract

The management of atrial fibrillation (AF) has seen marked changes in past years, with the introduction of new oral anticoagulants, new antiarrhythmic drugs, and the emergence of catheter ablation as a common intervention for rhythm control. Furthermore, new technologies enhance our ability to detect AF. Most clinical management decisions in AF patients can be based on validated parameters that encompass type of presentation, clinical factors, electrocardiogram analysis, and cardiac imaging. Despite these advances, patients with AF are still at increased risk for death, stroke, heart failure, and hospitalizations. During the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association (AFNET/EHRA) consensus conference, we identified the following opportunities to personalize management of AF in a better manner with a view to improve outcomes by integrating atrial morphology and damage, brain imaging, information on genetic predisposition, systemic or local inflammation, and markers for cardiac strain. Each of these promising avenues requires validation in the context of existing risk factors in patients. More importantly, a new taxonomy of AF may be needed based on the pathophysiological type of AF to allow personalized management of AF to come to full fruition. Continued translational research efforts are needed to personalize management of this prevalent disease in a better manner. All the efforts are expected to improve the management of patients with AF based on personalized therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/europace/eut232

Cites

227 of 227 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Preoperative statin therapy for patients undergoing cardiac surgery
Liakopoulos, O. J., Kuhn, E. W., Slottosch, I., Wassmer, G., & Wahlers, T. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008493.pub2 · Cited by 145
Retracted
Dabigatran versus warfarin in patients with atrial fibrillation
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P. A., Themeles, E., Varrone, J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905561 · Cited by 11,215
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
Patel, M. R., Mahaffey, K. W., Garg, J., Pan, G., Singer, D. E., Hacke, W., Breithardt, G., Halperin, J. L., Hankey, G. J., Piccini, J. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009638 · Cited by 9,430
Self-citation
Apixaban versus warfarin in patients with atrial fibrillation
Granger, C. B., Alexander, J. H., McMurray, J. J. V., Lopes, R. D., Hylek, E. M., Hanna, M., Al-Khalidi, H. R., Ansell, J., Atar, D., Avezum, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1107039 · Cited by 8,943
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
Authors/Task Force Members, McMurray, J. J. V., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., Falk, V., Filippatos, G., Fonseca, C., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs104 · Cited by 6,879
Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Kirchhof, P. F., Lip, G. Y. H., Schotten, U., Savelieva, I., Ernst, S., Gelder, I. C. V., Al‐Attar, N., Hindricks, G., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq278 · Cited by 5,924
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
Pisters, R., Lane, D. A., Nieuwlaat, R., de Vos, C. B., Crijns, H. J. G. M., & Lip, G. Y. H. (2010) · CHEST Journal · doi:10.1378/chest.10-0134 · Cited by 4,517
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors Task Force Members, Camm, A. J., Lip, G. Y. H., Caterina, R. D., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P. F., Bax, J. J., et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,823
2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Calkins, H., Kuck, K. H., Cappato, R., Brugada, J., Camm, A. J., Chen, S.-A., Crijns, H. J. G., Damiano, R. J., Davies, D. W., DiMarco, J., et al. (2012) · Europace · doi:10.1093/europace/eus027 · Cited by 2,722
American Journal of Neuroradiology
(2020) · American Journal of Neuroradiology · doi:10.3174/ajnr · Cited by 2,468

Show all 227 references

Research works printed but not linked: 6

2012, 2012, 1177
Bikkina, 1994, JAMA, 272, 33, 10.1001/jama.1994.03520010045030 · DOI
Lechleitner, 1991, Zeitschrift f r Kardiologie, 80, 574
Liakopoulos, 2012, Cochrane database of systematic reviews (Online), 4, CD008493
2009, Circulation: Arrhythmia and Electrophysiology, 3, 46
2012, Europace, 14, 8, 10.1093/europace/eur241 · DOI

Sorted by citations

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS)
Task Force Members, Lip, G. Y. H., Windecker, S., Huber, K., Kirchhof, P. F., Marín, F. R., ten Berg, J. M., Hæusler, K. G., Boriani, G., Capodanno, D., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu298 · Cited by 573
The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
Hijazi, Z., Oldgren, J., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Held, C., Hylek, E. M., Lopes, R. D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00741-8 · Cited by 490
The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
Hijazi, Z., Lindbäck, J., Alexander, J. H., Hanna, M., Held, C., Hylek, E. M., Lopes, R. D., Oldgren, J., Siegbahn, A., Stewart, R. A. H., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw054 · Cited by 437
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry
Boriani, G., Laroche, C., Diemberger, I., Fantecchi, E., Popescu, M. I., Rasmussen, L. H., Sinagra, G., Petrescu, L., Tavazzi, L., Maggioni, A. P., et al. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.11.026 · Cited by 344
Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality
Vermond, R. A., Geelhoed, B., Verweij, N., Tieleman, R. G., Van der Harst, P., Hillege, H. L., Van Gilst, W. H., Van Gelder, I. C., & Rienstra, M. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1314 · Cited by 297
Early management of atrial fibrillation to prevent cardiovascular complications
Nattel, S., Guasch, E., Savelieva, I., Cosío, F. G., Valverde, I., Halperin, J. L., Conroy, J. M., Al‐Khatib, S. M., Hess, P. L., Kirchhof, P. F., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu028 · Cited by 274
Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population
Reiffel, J. A., Verma, A., Kowey, P. R., Halperin, J. L., Gersh, B. J., Wachter, R., Pouliot, E., Ziegler, P., & for the REVEAL AF Investigators (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.3180 · Cited by 267
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation
Goldberger, J. J., Arora, R., Green, D., Greenland, P., Lee, D. C., Lloyd‐Jones, D. M., Markl, M., Ng, J., & Shah, S. J. (2015) · Circulation · doi:10.1161/circulationaha.115.016795 · Cited by 247
Atrial fibrillation
Lip, G. Y. H., Fauchier, L., Freedman, S. B., Gelder, I. C. V., Natale, A., Gianni, C., Nattel, S., Potpara, T., Rienstra, M., Tse, H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.16 · Cited by 248
The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis
Heijman, J., Algalarrondo, V., Voigt, N., Melka, J., Wehrens, X. H. T., Dobrev, D., & Nattel, S. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv275 · Cited by 198
Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Boriani, G., Savelieva, I., Dan, G., Deharo, J., Ferro, C. J., Israel, C. W., Lane, D. A., Manna, G. L., Morton, J. B., Moya‐Mitjans, À., et al. (2015) · EP Europace · doi:10.1093/europace/euv202 · Cited by 187
The future of atrial fibrillation management: integrated care and stratified therapy
Kirchhof, P. F. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31072-3 · Cited by 182
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies
Sinner, M. F., Stepas, K. A., Moser, C., Krijthe, B. P., Aspelund, T., Sotoodehnia, N., Fontes, J. D., Janssens, A. C. J. W., Kronmal, R. A., Magnani, J. W., et al. (2014) · EP Europace · doi:10.1093/europace/euu175 · Cited by 172
Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation
Nattel, S., & Dobrev, D. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.118 · Cited by 172
The HARMONY Trial
Reiffel, J. A., Camm, A. J., Belardinelli, L., Zeng, D., Karwatowska‐Prokopczuk, E., Olmsted, A., Zaręba, W., Rosero, S. Z., & Kowey, P. R. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.115.002856 · Cited by 164
10-year nationwide trends of the incidence, prevalence, and adverse outcomes of non-valvular atrial fibrillation nationwide health insurance data covering the entire Korean population
Kim, D., Yang, P., Jang, E., Yu, H. T., Kim, T., Uhm, J., Kim, J., Pak, H., Lee, M., Joung, B., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.04.017 · Cited by 160
Atrial Fibrillation: Mechanisms, Therapeutics, and Future Directions
Pellman, J., & Sheikh, F. (2015) · Comprehensive physiology · doi:10.1002/cphy.c140047 · Cited by 191
Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulacion Cardiaca y Electrofisiologia (SOLEACE)
Lane, D. A., Aguinaga, L., Blomström-Lundqvist, C., Boriani, G., Dan, G.-A., Hills, M. T., Hylek, E. M., LaHaye, S. A., Lip, G. Y. H., Lobban, T., et al. (2015) · Europace · doi:10.1093/europace/euv233 · Cited by 142
Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment
Fabritz, L., Guasch, E., Antoniades, C. A., Bardinet, I., Benninger, G., Betts, T. R., Brand, E., BREITHARDT, G. E., Suchánková, G., Camm, A. J., et al. (2015) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2015.194 · Cited by 144
A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference
Kirchhof, P. F., BREITHARDT, G. E., Bax, J. J., Benninger, G., Blomström‐Lundqvist, C., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H. G., et al. (2015) · EP Europace · doi:10.1093/europace/euv304 · Cited by 143
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · EP Europace · doi:10.1093/europace/euw242 · Cited by 134
Catheter ablation of atrial fibrillation: an update
Haegeli, L., & Calkins, H. G. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu291 · Cited by 123
Predisposing factors for atrial fibrillation in the elderly.
Wasmer, K., Eckardt, L., & BREITHARDT, G. E. (2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.03.010 · Cited by 126
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation
Oldgren, J., Hijazi, Z., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Hylek, E. M., Lópes, R. D., et al. (2016) · Circulation · doi:10.1161/circulationaha.116.022802 · Cited by 107
European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)
Görenek, B., Pelliccia, A., Benjamin, E. J., Boriani, G., Crijns, H. J. G. M., Fogel, R. I., Gelder, I. C. V., Halle, M., Kudaiberdieva, G., Lane, D. A., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676037 · Cited by 104
Study of molecular events in cells by fluorescence correlation spectroscopy
Vukojević, V. B., Pramanik, A., Yakovleva, T., Rigler, R. W., Terenius, L. Y., & Bakalkin, G. Y. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4305-7 · Cited by 94
Rhythm Control in Heart Failure Patients With Atrial Fibrillation
Trulock, K. M., Narayan, S. M., & Piccini, J. P. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.06.1169 · Cited by 92
The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial
Verma, A., Ha, A. C. T., Kirchhof, P. F., Hindricks, G., Healey, J. S., Hill, M. D., Sharma, M., Wyse, D. G., Champagne, J., Essebag, V., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.12.007 · Cited by 91
The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology
Kirchhof, P. F., Medicine, E. C. R. A. E. A. W. S. O. P., Sipido, K. R., Medicine, E. C. R. A. E. A. W. S. O. P., Cowie, M., Medicine, E. C. R. A. E. A. W. S. O. P., Eschenhagen, T., Medicine, E. C. R. A. E. A. W. S. O. P., Fox, K. A. A., Medicine, E. C. R. A. E. A. W. S. O. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu312 · Cited by 93
Atrial fibrillation burden and atrial fibrillation type: Clinical significance and impact on the risk of stroke and decision making for long-term anticoagulation
Boriani, G., & Pettorelli, D. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.03.006 · Cited by 85
Current controversies in determining the main mechanisms of atrial fibrillation
Schotten, U., Dobrev, D., Platonov, P. G., Kottkamp, H., & Hindricks, G. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12492 · Cited by 83
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
Willems, S., Meyer, C. G., de Bono, J. P., Brandes, A., Eckardt, L., Elvan, A., Gelder, I. C. V., Goette, A., Gulizia, M. M., Haegeli, L., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz782 · Cited by 80
Association of pre-ablation level of potential blood markers with atrial fibrillation recurrence after catheter ablation: a meta-analysis
Jiang, H., Wang, W., Wang, C., Xie, X., & Hou, Y. (2016) · EP Europace · doi:10.1093/europace/euw088 · Cited by 80
Influence of Inflammation and Atherosclerosis in Atrial Fibrillation
da Silva, R. M. F. L. (2017) · Current Atherosclerosis Reports · doi:10.1007/s11883-017-0639-0 · Cited by 77
Improving clinical trials for cardiovascular diseases: a position paper from the Cardiovascular Round Table of the European Society of Cardiology
Jackson, N. C., Atar, D., Borentain, M., Breithardt, G., van Eickels, M., Endres, M., Fraass, U., Friede, T., Hannachi, H., Janmohamed, S. G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv213 · Cited by 79
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
Hijazi, Z., Wallentin, L. C., Lindbäck, J., Alexander, J. H., Connolly, S. J., Eikelboom, J. W., Ezekowitz, M. D., Granger, C. B., Lópes, R. D., Pol, T., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.018984 · Cited by 63
Atrial Myopathy Underlying Atrial Fibrillation
Rivner, H., Mitrani, R. D., & Goldberger, J. J. (2020) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.13 · Cited by 64
The ECG as a tool to determine atrial fibrillation complexity
Lankveld, T., Zeemering, S., Crijns, H. J. G. M., & Schotten, U. (2014) · Heart · doi:10.1136/heartjnl-2013-305149 · Cited by 58
Major knowledge gaps and system barriers to guideline implementation among European physicians treating patients with atrial fibrillation: a European Society of Cardiology international educational needs assessment
Heidbüchel, H., Dagres, N., Antz, M., Kück, K., Lazure, P., Murray, S., Carrera, C., Hindricks, G., & Vahanian, A. S. (2018) · EP Europace · doi:10.1093/europace/euy039 · Cited by 58
Real-life experience with the specific reversal agent idarucizumab for the management of emergency situations in dabigatran-treated patients: a series of 11 cases
Voško, M. R., Bocksrucker, C., Drwiła, R., Ďulíček, P., Hauer, T., Mutzenbach, J. S., Schlimp, C. J., Špinler, D., Wolf, T. A., & Zugwitz, D. (2017) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-017-1476-2 · Cited by 56
Atrial fibrosis: an obligatory component of arrhythmia mechanisms in atrial fibrillation?
Platonov, P. G. (2017) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2017.03.009 · Cited by 49
Atrial fibrillation without comorbidities: Prevalence, incidence and prognosis (from the Framingham Heart Study)
Kim, E., Yin, X., Fontes, J. D., Magnani, J. W., Lubitz, S. A., McManus, D. D., Seshadri, S. S., Vasan, R. S., Ellinor, P. T., Larson, M. G., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.023 · Cited by 47
The burden of proof: The current state of atrial fibrillation prevention and treatment trials
Zakeri, R., Wagoner, D. R. V., Calkins, H. G., Wong, T., Ross, H., Heist, E. K., Meyer, T. E., Kowey, P. R., Mentz, R. J., Cleland, J. G. F., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.01.032 · Cited by 42
Anticoagulation after Catheter Ablation of Atrial Fibrillation Guided by Implantable Cardiac Monitors
Zuern, C. S., Kilias, A., Berlitz, P., Seizer, P., Gramlich, M., Müller, K., Duckheim, M., Gawaz, M., & Schreieck, J. (2015) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12625 · Cited by 43
Artificial intelligence for a personalized diagnosis and treatment of atrial fibrillation
Nava, A., Atienza, F., Bermejo, J., & Fernández‐Avilés, F. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00764.2020 · Cited by 43
Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study
Vermond, R. A., Crijns, H. J. G. M., Tijssen, J. G. P., ALINGS, A. M. W., van den Berg, M. P., Hillege, H. L., van Veldhuisen, D. J., Gelder, I. C. V., Rienstra, M., & for the RACE II investigators (2014) · EP Europace · doi:10.1093/europace/euu151 · Cited by 39
Updated NICE guideline: management of atrial fibrillation (2014)
Senoo, K., Lau, Y. C., & Lip, G. Y. H. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.943189 · Cited by 40
Usefulness of serum uric acid level to predict atrial fibrillation recurrence after cryoballoon-based catheter ablation
Canpolat, U., Aytemir, K., Yorgun, H., ahiner, L., Kaya, E. B., Çay, S., lu, S. T., Aras, D., & Oto, A. (2014) · EP Europace · doi:10.1093/europace/euu198 · Cited by 38
Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation
Siegbahn, A. G., Lindbäck, J., Hijazi, Z., Åberg, M., Alexander, J. H., Eikelboom, J. W., Lópes, R. D., Pol, T., Oldgren, J., Granger, C. B., et al. (2021) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.15498 · Cited by 36
A New Therapeutic Framework for Atrial Fibrillation Drug Development
Ang, Y.-S., Rajamani, S., Haldar, S. M., & Hüser, J. (2020) · Circulation Research · doi:10.1161/circresaha.120.316576 · Cited by 38
Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives
Hæusler, K. G., Wilson, D., Fiebach, J. B., Kirchhof, P. F., & Werring, D. J. (2014) · Heart · doi:10.1136/heartjnl-2013-305151 · Cited by 36
Prevalence of Atrial Fibrillation in Patients with High CHADS2‐ and CHA2DS2VASc‐Scores: Anticoagulate or Monitor High‐Risk Patients?
Tischer, T. S., SCHNEIDER, R., Lauschke, J., Neßelmann, C., Klemm, A. B., Diedrich, D., Kundt, G., & Bänsch, D. (2014) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12470 · Cited by 34
The changing circumstance of atrial fibrillation ‐ progress towards precision medicine
Camm, A. J., Savelieva, I., Potpara, T., Hindriks, G., Pison, L., & Blomström‐Lundqvist, C. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12478 · Cited by 30
Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community-based cohort: data of the PREVEND study
Hobbelt, A. H., Siland, J. E., Geelhoed, B., van der Harst, P., Hillege, H. L., Gelder, I. C. V., & Rienstra, M. (2016) · EP Europace · doi:10.1093/europace/euw016 · Cited by 31
Total cholesterol variability and risk of atrial fibrillation: A nationwide population-based cohort study
Roh, E., Chung, H. S., Lee, J. S., Kim, J. A., Lee, Y., Hong, S., Kim, N. H., Yoo, H. J., Seo, J. A., Kim, S. G., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215687 · Cited by 27
Clinical and economic outcomes of a systematic same-day discharge programme after pulmonary vein isolation: comparison between cryoballoon vs. radiofrequency ablation
Jiménez‐Candil, J., Hernández‐Rivas, J. M., Galbán, A. C., Blanco-Fernández, F., Morinigo, J., García, M., Manzanas, A. O., & Sanchez, P. L. (2023) · EP Europace · doi:10.1093/europace/euad265 · Cited by 26
Natriuretic Propeptides as Markers of Atrial Fibrillation Burden and Recurrence (from the AMIO-CAT Trial)
Darkner, S., Goetze, J. P., Chen, X., Henningsen, K. M. A., Pehrson, S. M., & Svendsen, J. H. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.018 · Cited by 25
Systematic comparison of non-invasive measures for the assessment of atrial fibrillation complexity: a step forward towards standardization of atrial fibrillation electrogram analysis
Bonizzi, P., Zeemering, S., Karel, J. M. H., Marco, L. Y. D., Uldry, L., Zaen, J. V., Vesin, J.-M., & Schotten, U. (2014) · EP Europace · doi:10.1093/europace/euu202 · Cited by 24
Atrial arrhythmias in the young: early onset atrial arrhythmias preceding a diagnosis of a primary muscular dystrophy
Stoyanov, N., Winterfield, J. R., Varma, N., & Gollob, M. H. (2014) · EP Europace · doi:10.1093/europace/euu141 · Cited by 24
Prediction and personalised treatment of atrial fibrillation—stroke prevention: consolidated position paper of CVD professionals
Helms, T. M., Duong, G., Zippel‐Schultz, B., Tilz, R. R., Kück, K., & Karle, C. A. (2014) · The EPMA Journal · doi:10.1186/1878-5085-5-15 · Cited by 23
Health literacy, health-related quality of life, and atrial fibrillation
Montbleau, K. E., King, D., Henault, L. E., & Magnani, J. W. (2017) · Cogent Medicine · doi:10.1080/2331205x.2017.1412121 · Cited by 23
An automated system using spatial oversampling for optical mapping in murine atria. Development and validation with monophasic and transmembrane action potentials
Yu, T. Y., Syeda, F., Holmes, A. P., Osborne, B., Dehghani, H., Brain, K. L., Kirchhof, P. F., & Fabritz, L. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.07.012 · Cited by 21
Atrial Fibrillation and SCN5A Variants
Galimberti, E. S., & Darbar, D. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2014.07.006 · Cited by 26
Non-valvular atrial fibrillation
Boriani, G., Cimaglia, P., Fantecchi, E., Mantovani, V., Ziacchi, M., Valzania, C., Martignani, C., Biffi, M., & Diemberger, I. (2015) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000236 · Cited by 21
Calcium signalling silencing in atrial fibrillation
Greiser, M. (2017) · The Journal of Physiology · doi:10.1113/jp273045 · Cited by 21
Altered Atrial Metabolism: An Underappreciated Contributor to the Initiation and Progression of Atrial Fibrillation
Ghezelbash, S., Molina, C. E., & Dobrev, D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001808 · Cited by 21
Prevalence and antithrombotic management of atrial fibrillation in hospitalised patients
Berti, D., Moors, E., Moons, P., & Heidbüchel, H. (2015) · Heart · doi:10.1136/heartjnl-2014-307059 · Cited by 20
Focal impulse and rotor modulation using the novel 64-electrode basket catheter: electrogram characteristics of human rotors
Lin, T., Rillig, A., Bucur, T., Metzner, A., Mathew, S., Wißner, E., Wohlmuth, P., Kück, K., Ouyang, F. O., & Tilz, R. R. (2015) · EP Europace · doi:10.1093/europace/euv282 · Cited by 19
Use of Cardiac Computed Tomography and Magnetic Resonance Imaging in Case Management of Atrial Fibrillation with Catheter Ablation
Lee, H., Shim, J., Choi, J., Kim, Y., Oh, Y., & Hwang, S. H. (2019) · Korean Journal of Radiology · doi:10.3348/kjr.2018.0774 · Cited by 19
Individualized approaches to thromboprophylaxis in atrial fibrillation
Ziff, O. J., & Camm, A. J. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.10.021 · Cited by 18
Inflammatory proteomics profiling for prediction of incident atrial fibrillation
Börschel, C. S., Ortega‐Alonso, A., Havulinna, A. S., Jousilahti, P., Salmi, M., Jalkanen, S., Salomaa, V. V., Niiranen, T., & Schnabel, R. B. (2023) · Heart · doi:10.1136/heartjnl-2022-321959 · Cited by 16
Multiphysics simulations reveal haemodynamic impacts of patient‐derived fibrosis‐related changes in left atrial tissue mechanics
Gonzalo, A., Augustin, C. M., Bifulco, S., Telle, Å., Chahine, Y., Kassar, A., Guerrero‐Hurtado, M., Durán, E., Martínez‐Legazpi, P., Flores, Ó., et al. (2024) · The Journal of Physiology · doi:10.1113/jp287011 · Cited by 18
Asymptomatic atrial fibrillation in patients with atrial fibrillation and implanted pacemaker
Witkowski, M., Bissinger, A., Grycewicz, T., & Lubiński, A. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.10.097 · Cited by 16
Predictors of New Onset Atrial Fibrillation Burden in the Critically Ill
Lancini, D. V., Sun, J. K., Mylonas, G., Boots, R. J., Atherton, J. J., Prasad, S. B., & Martin, P. T. (2023) · Cardiology · doi:10.1159/000534368 · Cited by 16
Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey
Pison, L., Hocini, M., Potpara, T. S., Todd, D., Chen, J., Blomström‐Lundqvist, C., Blomström‐Lundqvist, C., Bongiorni, M. G., Pison, L., Proclemer, A., et al. (2014) · EP Europace · doi:10.1093/europace/euu277 · Cited by 15
Calcium Signaling Silencing in Atrial Fibrillation: Implications for Atrial Sodium Homeostasis
Kaplan, A. D., Joca, H. C., Boyman, L., & Greiser, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910513 · Cited by 15
Validation of Conventional Thromboembolic Risk Factors in a Korean Atrial Fibrillation Population ― Suggestion for a Novel Scoring System, CHA2DS2-VAK ―
Cha, M., Cho, Y., Oh, I., Choi, E., & Oh, S. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-0218 · Cited by 15
Opportunities and challenges of current electrophysiology research: a plea to establish 'translational electrophysiology' curricula
Lau, D. H., Volders, P. G. A., Kohl, P. K., Prinzen, F. W., Zaza, A., Kääb, S., Oto, A., & Schotten, U. (2015) · EP Europace · doi:10.1093/europace/euu301 · Cited by 14
Of hammers and screws: renin-angiotensin-aldosterone system inhibition to prevent atrial fibrillation in patients with hypertension
Kirchhof, P. F., & Fabritz, L. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu068 · Cited by 12
Prevalence of atrial fibrillation and the HATCH score
Tischer, T. S., Schneider, R., Lauschke, J., Diedrich, D., Kundt, G., & Bänsch, D. (2015) · Herz · doi:10.1007/s00059-015-4305-4 · Cited by 11
Vernakalant activates human cardiac K2P17.1 background K+ channels
Seyler, C., Schweizer, P. A., Zitron, E., Katus, H. A., & Thomas, D. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.07.133 · Cited by 11
Role of Biological Markers for Cerebral Bleeding Risk STRATification in Patients with Atrial Fibrillation on Oral Anticoagulants for Primary or Secondary Prevention of Ischemic Stroke (Strat-AF Study): Study Design and Methodology
Poggesi, A., Barbato, C., Galmozzi, F., Camilleri, E., Cesari, F., Chiti, S., Diciotti, S., Galora, S., Giusti, B., Gori, A. M., et al. (2019) · Medicina · doi:10.3390/medicina55100626 · Cited by 11
Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
Arai, S., Kawamura, M., Gokan, T., Yoshikawa, K., Ogawa, K., Ochi, A., Munetsugu, Y., Ito, H., & Shinke, T. (2020) · Clinical Cardiology · doi:10.1002/clc.23471 · Cited by 11
Gwas Contribution to Atrial Fibrillation and Atrial Fibrillation-Related Stroke: Pathophysiological Implications
Cruz, D., Pinto, R., Freitas-Silva, M., Nunes, J. P. L., & Medeiros, R. (2019) · Pharmacogenomics · doi:10.2217/pgs-2019-0054 · Cited by 9
Epstein Barr Virus and Atrial Fibrillation
Barukčić, I. (2019) · Modern Health Science · doi:10.30560/mhs.v2n1p1 · Cited by 8
Therapeutic Futility and Phenotypic Heterogeneity in Heart Failure with Preserved Ejection Fraction: What is the Role of Bionic Learning?
Kao, D. P., Purohit, S., & Jhund, P. S. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1658 · Cited by 8
Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations
Rienstra, M., Geelhoed, B., Yin, X., Siland, J. E., Vermond, R. A., Mulder, B. A., van der Harst, P., Hillege, H. L., Benjamin, E. J., & Gelder, I. C. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165828 · Cited by 7
Pathophysiology of Idiopathic Atrial Fibrillation - Prognostic and Treatment Implications
Weijs, B., Schotten, U., & Crijns, H. J. G. M. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140825150057 · Cited by 7
A Clinical Perspective on Atrial Fibrillation
Platonov, P. G., & Corino, V. (2018) · Series in bioengineering · doi:10.1007/978-3-319-68515-1_1 · Cited by 7
The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results
Schotten, U., Hatem, S. N., Ravens, U., Jaı̈s, P., Müller, F.-U., Goette, A., Rohr, S., Antoons, G., Pieske, B. M., Scherr, D., et al. (2015) · EP Europace · doi:10.1093/europace/euv252 · Cited by 7
Use of MRI for Risk Stratification in Anticoagulation Decision Making in Atrial Fibrillation: Promising, but More Data are Needed for a Robust Algorithm
Wilson, D., Charidimou, A., & Werring, D. J. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00003 · Cited by 6
Biomarkers and atrial fibrillation: is it prime time yet?
Mahajan, R., Lau, D. H., & Sanders, P. (2014) · Heart · doi:10.1136/heartjnl-2014-306008 · Cited by 6
Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: new recommendations for daily practice
Boriani, G., Lane, D. A., Windecker, S., Huber, K., Kirchhof, P. F., & Lip, G. Y. H. (2015) · EP Europace · doi:10.1093/europace/euu303 · Cited by 6
Symptom Status, Clinical Subtypes, and Prognosis in Patients With Atrial Fibrillation from the Middle East Region (from the Gulf-SAFE Registry)
Xie, P.-X., Li, Y.-G., Alsheikh-Ali, A. A., Almahmeed, W. A., Shehab, A., Sulaiman, K., Asaad, N., Guo, L.-J., Liu, S.-W., Zubaid, M., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.12.060 · Cited by 5
Subepicardial adipose tissue as a modulator of arrhythmias
Pyman, E., Ernault, A. C., Patel, K. H. K., Ng, F. S., & Coronel, R. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.10.023 · Cited by 5
A new look at atrial fibrillation: lessons learned from drugs, pacing, and ablation therapies
KAPPENBERGER, L. J. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht252 · Cited by 5
A Year in the Life of a Person Recently Diagnosed with Atrial Fibrillation: a Danish Single-Case Study.
Høgh, V., Cummings, E. A., Riahi, S., Lundbye‐Christensen, S., Frederiksen, K., & Delmar, C. (2015) · The International Journal of Person Centered Medicine · doi:10.5750/ijpcm.v5i4.533 · Cited by 5

Authors: Kirchhof, P., Breithardt, G., Aliot, E., Al Khatib, S., Apostolakis, S., Auricchio, A., Bailleul, C., Bax, J., Benninger, G., Blomstrom-Lundqvist, C., Boersma, L., Boriani, G., Brandes, A., Brown, H., Brueckmann, M., Calkins, H., Casadei, B., Clemens, A., Crijns, H., Derwand, R., Dobrev, D., Ezekowitz, M., Fetsch, T., Gerth, A., Gillis, A., Gulizia, M., Hack, G., Haegeli, L., Hatem, S., Georg Hausler, K., Heidbuchel, H., Hernandez-Brichis, J., Jais, P., Kappenberger, L., Kautzner, J., Kim, S., Kuck, K.-H., Lane, D., Leute, A., Lewalter, T., Meyer, R., Mont, L., Moses, G., Mueller, M., Munzel, F., Nabauer, M., Nielsen, J. C., Oeff, M., Oto, A., Pieske, B., Pisters, R., Potpara, T., Rasmussen, L., Ravens, U., Reiffel, J., Richard-Lordereau, I., Schafer, H., Schotten, U., Stegink, W., Stein, K., Steinbeck, G., Szumowski, L., Tavazzi, L., Themistoclakis, S., Thomitzek, K., Van Gelder, I. C., von Stritzky, B., Vincent, A., Werring, D., Willems, S., Lip, G. Y. H., & Camm, A. J.
Affiliations: University Hospital Münster (DE)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
University of Birmingham (GB)
Istituto Cardiocentro Ticino (CH)
St. Jude Medical (United States) (US)
Leiden University (NL)
St. Antonius Ziekenhuis (NL)
University of Bologna (IT)
Odense University Hospital (DK)
Boehringer Ingelheim (Germany) (DE)
Johns Hopkins University (US)
University of Oxford (GB)
Maastricht University Medical Centre (NL)
Daiichi Sankyo (Germany) (DE)
University of Duisburg-Essen (DE)
Lankenau Institute for Medical Research (US)
Ludwig-Maximilians-Universität München (DE)
University of Calgary (CA)
Ospedale Garibaldi (IT)
Bristol-Myers Squibb (Germany) (DE)
University Hospital Zurich (CH)
Sorbonne Université (FR)
Universitair Ziekenhuis Leuven (BE)
University of Lausanne (CH)
Institute of Clinical and Experimental Medicine (CZ)
Asklepios Klinik St. Georg (DE)
TUM Klinikum (DE)
Medtronic (Switzerland) (CH)
Hospital Clínic de Barcelona (ES)
Pfizer (Germany) (DE)
Aarhus University Hospital (DK)
Atrial Fibrillation NETwork (DE)
Hacettepe University (TR)
Medical University of Graz (AT)
University of Belgrade (RS)
Columbia University Irving Medical Center (US)
Bayer (Germany) (DE)
Boston Scientific (United States) (US)
Starnberg Hospital (DE)
University College Hospital (GB)
Uppsala University (SE)
ORCID: Kirchhof, P.
Auricchio, A.
Bailleul, C.
Bax, J.
Boersma, L.
Boriani, G.
Brandes, A.
Brueckmann, M.
Calkins, H.
Casadei, B.
Clemens, A.
Crijns, H.
Dobrev, D.
Gerth, A.
Gillis, A.
Gulizia, M.
Hack, G.
Haegeli, L.
Hatem, S.
Kautzner, J.
Lane, D.
Lewalter, T.
Meyer, R.
Mont, L.
Nielsen, J. C.
Pieske, B.
Pisters, R.
Potpara, T.
Ravens, U.
Reiffel, J.
Schotten, U.
Steinbeck, G.
Tavazzi, L.
Themistoclakis, S.
Thomitzek, K.
Werring, D.
Lip, G. Y. H.
Camm, A. J.
Venue: Europace
Publisher: Oxford University Press (OUP)
Published: 2013-08-27
Volume: 15
Issue: 11
Pages: 1540-1556
ISSN: 1099-5129 (ISSN-L)
1532-2092
DOI: 10.1093/europace/eut232
OpenAlex: W2105963090
Cited by: 141
References: 227
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 4 · 2021: 4 · 2020: 7 · 2019: 11 · 2018: 8 · 2017: 18 · 2016: 20 · 2015: 26 · 2014: 29 · 2013: 2
FWCI: 17.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: EP Europace (publishedVersion)
PubMed (publishedVersion)
Research Publications (Maastricht University) (publishedVersion, other-oa)
University of Birmingham Research Portal (University of Birmingham) (publishedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion)
Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Leiden Repository (Leiden University) (submittedVersion)
Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
UCL Discovery (University College London) (submittedVersion)
IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
Pure Amsterdam UMC (submittedVersion)
University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
INFM-OAR (INFN Catania) (submittedVersion, other-oa)
Research Publications (Maastricht University) (submittedVersion, other-oa)
Funders: Wellcome Trust (090532)
Kompetenznetz Vorhofflimmern
British Heart Foundation (RG/11/15/29375)
European Commission
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Keywords: atrial fibrillation, personalized medicine, risk stratification, direct oral anticoagulants, antiarrhythmic drugs, catheter ablation, rhythm control, atrial morphology, neuroimaging, genetic susceptibility, inflammation, stroke risk, heart failure
MeSH terms: Atrial Fibrillation, Brain, Echocardiography, Electrocardiography, Humans, Magnetic Resonance Imaging, Risk Factors, Biomarkers, Treatment Outcome, Disease Management, Precision Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks